Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-31 @ 11:01 PM
Study NCT ID:
NCT03341494
Status:
UNKNOWN
Last Update Posted:
2017-11-14
First Post:
2017-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide
Sponsor:
Fujian Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-06
First Submit QC Date:
None
Study First Post Date:
2017-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-12
Last Update Post Date:
2017-11-14
Last Update Post Date Type:
ACTUAL